SCHEMBL19124979

SCHEMBL19124979

c1ccc(-c2cnnnc2N2CCNCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 6/20 0.55
▸ HTR1A P08908 5/20 0.55
▸ HTR6 P50406 4/20 0.55
▸ HTR2A P28223 1/20 0.55
▸ HTR5A P47898 1/20 0.55
▸ HTR2B P41595 2/20 0.46
▸ HTR2C P28335 1/20 0.45
▸ CSNK1D P48730 1/20 0.45
▸ MAPK11 Q15759 1/20 0.45
▸ MAPK14 Q16539 1/20 0.45
▸ CYP1A2 P05177 4/20 0.44
▸ CYP3A4 P08684 4/20 0.44
▸ CYP2D6 P10635 4/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ RECQL P46063 1/20 0.44
▸ HTR3A P46098 2/20 0.43
▸ HTR3E A5X5Y0 1/20 0.43
▸ HTR3B O95264 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753134 0.77 HTR7 (0.57) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL9048996 0.76 CYP1A2 (0.68) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL3319555 0.75 HTR7 (0.58) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL4560009 0.74 HRH4 (0.54) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL3759275 0.72 HTR7 (1.00) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL30022433 0.72 HTR7 (1.00) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL18346578 0.71 CSNK1D (0.60) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL14791703 0.71 HTR7 (0.43) HTR7HTR1AHTR6HTR2AHTR5A
Hydrochloric Acid SCHEMBL1673713 0.70 HTR7 (0.96) HTR7HTR1AHTR6HTR2AHTR5A
SCHEMBL2403314 0.70 HRH4 (0.47) HTR7HTR1AHTR6HTR2BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106661003-B alpha-helical analogs with triazine-piperazine backbones and methods of making the same 株式会社POSCO 2020-05-19 — — CN disclosed
US-10131650-B2 Alpha-helix analog having triazine-piperazine backbone and method for preparing same POSCO (KR) 2018-11-20 — — US disclosed
US-20170204086-A1 ALPHA-HELIX ANALOG HAVING TRIAZINE-PIPERAZINE BACKBONE AND METHOD FOR PREPARING SAME POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2017-07-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204086-A1 ALPHA-HELIX ANALOG HAVING TRIAZINE-PIPERAZINE BACKBONE AND METHOD FOR PREPARING SAME HSPH1, HBZ, PITHD1 HTR7 837/4885HTR1A 1702/4885HTR6 1793/4885
US-10131650-B2 Alpha-helix analog having triazine-piperazine backbone and method for preparing same HSPH1, HBZ, PITHD1 HTR7 837/4885HTR1A 1702/4885HTR6 1793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback